Literature DB >> 34077642

Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.

Nathalie E Blachere1, Ezgi Hacisuleyman1, Robert B Darnell1.   

Abstract

Entities:  

Year:  2021        PMID： 34077642     DOI： 10.1056/NEJMc2107808

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Authors:  Shelan Liu; Min Kang; Na Zhao; Yali Zhuang; Shijian Li; Tie Song
Journal:  Med Rev (Berl)       Date:  2022-05-25

Review 2.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

Review 3.  Drug delivery systems for RNA therapeutics.

Authors:  Kalina Paunovska; David Loughrey; James E Dahlman
Journal:  Nat Rev Genet       Date:  2022-01-04       Impact factor: 59.581

4.  SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.

Authors:  Aayush Gupta; Rahul Bhoyar; Shahzad Mirza; Bani Jolly; Vigneshwar Senthivel; Afra Shamnath; Mohit Kumar Divakar; Mohamed Imran; Vishu Gupta; Srashti Jyoti Agrawal; Sahjid Mukhida; Sridhar Sivasubbu; Vinod Scaria
Journal:  J Infect       Date:  2021-10-19       Impact factor: 6.072

5.  Comorbidities and Vaccination Status of COVID-19 All-Cause Mortality at a Tertiary Care Center of Western India.

Authors:  Manoj Verma; Savitri Sharma; Arun Kumar; Afzal Hakim; Suman Bhansali; Rita Meena
Journal:  Cureus       Date:  2022-01-30

6.  Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.

Authors:  Sushil Rayamajhi; Md Abdur Rafi; Nishant Tripathi; Anjana Singh Dongol; Minalma Pandey; Shreejana Rayamajhi; Subhechchha Bhandari; Pranay Shrestha; M Tasdik Hasan; Md Golam Hossain
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

7.  The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.

Authors:  Quan Liu; Heming Wang; He Zhang; Liyan Sui; Letian Li; Wang Xu; Shouwen Du; Pengfei Hao; Yuhang Jiang; Jing Chen; Xiaoyun Qu; Mingyao Tian; Yinghua Zhao; Xuerui Guo; Xingye Wang; Wu Song; Guangqi Song; Zhengkai Wei; Zhijun Hou; Guoqing Wang; Minhua Sun; Xiao Li; Huijun Lu; Xinyu Zhuang; Ningyi Jin; Yicheng Zhao; Chang Li; Ming Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-12       Impact factor: 12.779

8.  Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity.

Authors:  Yoonjung Kim; Joon-Yong Bae; Man-Seong Park; Shin-Woo Kim; Kitae Kwon; Hyun-Ha Chang; Won Kee Lee; Heedo Park; Jeonghun Kim; Isaac Choi
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

9.  In vitro inhibition of SARS-CoV-2 Infection by dry algae powders.

Authors:  Daniel Garcia-Ruiz; Erendira Villalobos-Sánchez; David Alam-Escamilla; Darwin Elizondo-Quiroga
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

10.  Therapeutic prevention of COVID-19 in elderly: a case-control study.

Authors:  Frederic Blanc; Cedric Waechter; Thomas Vogel; Benoit Schorr; Catherine Demuynck; Catherine Martin Hunyadi; Maxence Meyer; Denata Mutelica; Nadjiba Bougaa; Samira Fafi-Kremer; Lidia Calabrese; Elise Schmitt; Delphine Imperiale; Catherine Jehl; Alexandre Boussuge; Carmen Suna; François Weill; Alexia Matzinger; Candice Muller; Patrick Karcher; Georges Kaltenbach; Erik Sauleau
Journal:  Geroscience       Date:  2021-07-17       Impact factor: 7.713
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.